Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) Invested Capital (2016 - 2025)

Mesa Laboratories' Invested Capital history spans 15 years, with the latest figure at $191.8 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 24.02% year-over-year to $191.8 million; the TTM value through Dec 2025 reached $191.8 million, down 24.02%, while the annual FY2025 figure was $163.6 million, 12.51% up from the prior year.
  • Invested Capital for Q4 2025 was $191.8 million at Mesa Laboratories, up from $178.5 million in the prior quarter.
  • Across five years, Invested Capital topped out at $406.2 million in Q1 2021 and bottomed at $145.4 million in Q1 2024.
  • The 5-year median for Invested Capital is $383.8 million (2022), against an average of $311.5 million.
  • The largest annual shift saw Invested Capital soared 84.22% in 2021 before it crashed 63.05% in 2024.
  • A 5-year view of Invested Capital shows it stood at $396.3 million in 2021, then dropped by 2.3% to $387.2 million in 2022, then rose by 4.07% to $403.0 million in 2023, then plummeted by 37.34% to $252.5 million in 2024, then decreased by 24.02% to $191.8 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Invested Capital are $191.8 million (Q4 2025), $178.5 million (Q3 2025), and $176.7 million (Q2 2025).